This is the authors' abstract. We don't add key points for this paper.
Background Women with inflammatory rheumatic and musculoskeletal disease (iRMD) face unique challenges during preconception, pregnancy, and lactation. In 2024, a specialised consultation service was developed and implemented at the tertiary rheumatology centre of the Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany, to address these specific needs. Methods Demographic characteristics, disease- and treatment-related data, reproductive status, referring physician, reasons for consultation, and recommendations for disease management were collected between 1 January 2024 and 3 April 2025. Results Overall, 57 patients were included; the mean age was 33.3 ± 4.4 years and the mean disease duration was 6.3 ± 4.8 years. Almost all patients (94.7%) had a confirmed diagnosis of an iRMD. 57.9% were planning a pregnancy, 40.4% were pregnant, and 1.8% were breastfeeding. At baseline, 21.8% were receiving csDMARDs and 50.9% were receiving bDMARDs. Glucocorticoid use was documented in 16.1%. Patients were referred by rheumatologists (35.7%), the in-house outpatient clinic (37.5%), general practitioners (14.3%), gynaecologists (10.7%), and the in-house inpatient clinic (1.8%). The most frequent reasons for consultation were patient concerns regarding pregnancy and medication safety. Consultation reasons differed descriptively between patients in the preconception period and pregnant patients; however, these exploratory differences should be interpreted with caution. Recommendations made during consultation included modification of DMARD therapy (35.1%), initiation of fetal bradycardia screening (19.3%), and preeclampsia prophylaxis (8.8%). Conclusion A dedicated reproductive rheumatology consultation service provides structured support for women with iRMDs throughout preconception, pregnancy, and lactation. Medication adjustments and targeted preventive measures were recommended for more than one-third of patients, highlighting the potential value of preconception referral and specialized reproductive rheumatology consultation. Clinical trial number Not applicable.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vossen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: